Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

NCT06873334 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington Disease
Huntingtons Disease

Interventions

DRUG: SKY-0515
DRUG: SKY-0515 Placebo

Sponsor

Skyhawk Therapeutics, Inc.